Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stromal Vascular Fraction for Peyronie's Disease
NCT04771442Phase 1Completed
- Sponsor
- Esbjerg Hospital - University Hospital of Southern Denmark
- Start
- Sep 2022
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous adipose stromal vascular fraction in Peyronie's disease, sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Primary endpoint: Change in the bend of the erect penis at 12 months. Started Sep 2022; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT04771442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771442.